C
C10AB04 Gemfibrozil
[C10AB] Fibrates
[C10A] LIPID MODIFYING AGENTS, PLAIN
[C10] LIPID MODIFYING AGENTS
[C] Cardiovascular system
Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
UNCOUPLING | rat | isolated liver mitochondria | measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay | Negative | 53 | |||
ELECTRON TRANSPORT CHAIN | isolated mitochondria | decrease | 7 | |||||
ELECTRON TRANSPORT CHAIN | rat | isolated liver mitochondria | measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay | Negative | 53 | |||
Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
NADH:ubiquinone reductase | isolated mitochondria | inhibitor | 7 | |||||
Pictogram | Signal | Statements | Precautionary Statement Codes |
---|---|---|---|
Warning |
Aggregated GHS information provided by 131 companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. Reported as not meeting GHS hazard criteria by 1 of 131 companies. For more detailed information, please visit ECHA C&L website Of the 9 notification(s) provided by 130 of 131 companies with hazard statement code(s): H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] H351 (24.62%): Suspected of causing cancer [Warning Carcinogenicity] H361 (26.15%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] H411 (24.62%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P264, P270, P273, P281, P301+P312, P308+P313, P330, P391, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) | |
Danger |
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] H350 (100%): May cause cancer [Danger Carcinogenicity] H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] |
P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) | |
2,2-Dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid | 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid | 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure |
2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeric Acid | 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure | 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid |
2,2-Dimethyl-5-(2,5-zlyloxy)valeric acid | 25812-30-0 | 4TX |
5-(2,5-Dimethyl-Phenoxy)-2,2-Dimethyl-Pentanoic Acid | 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid | 5-(2,5-dimethylphenoxy)-2,2- |
5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid | 5-[(2,5-dimethylphenyl)oxy]-2,2-dimethylpentanoic acid | A0G461 |
A818037 | AB00052003 | AB00052003-15 |
AB00052003-16 | AB00052003_17 | AB00052003_18 |
AB0013344 | AB03034 | AB2000253 |
AC-4225 | AK309283 | AKOS001606691 |
API0002816 | ARONIS24091 | AX8032912 |
Apo-Gemfibrozil | Ausgem | BBC/228 |
BBL010807 | BB_SC-04837 | BCP08437 |
BDBM50110590 | BG0205 | BPBio1_000251 |
BRD-K11129031-001-05-1 | BRN 1881200 | BSPBio_000227 |
BSPBio_002060 | Bolutol | Brozil |
C-15436 | C07020 | CAS-25812-30-0 |
CC-28946 | CCG-40111 | CCRIS 318 |
CG0035 | CHEBI:5296 | CHEMBL457 |
CI 719 | CI-719 | CPD000058393 |
CS-2244 | Certified Reference Material | Cholespid |
Clearol | D00334 | DB01241 |
DL-414 | DSSTox_CID_652 | DSSTox_GSID_20652 |
DSSTox_RID_75712 | DTXSID0020652 | Decrelip |
DivK1c_000138 | EINECS 247-280-2 | Elmogan |
FT-0626641 | FT-0700924 | Fetinor |
Fibratol | Fibrocit | G0368 |
GEMFIBROZIL (SEE ALSO PEROXISOME PROJECT (GEMFIBROZIL)) | GP1460 | GTPL3439 |
Gem-S | Gemcor | Gemcor;Jezil;Gen-Fibro;Lopid |
Gemd | Gemfibril | Gemfibromax |
Gemfibrosil | Gemfibrozil (JAN/USP/INN) | Gemfibrozil (Lopid) |
Gemfibrozil [USAN:BAN:INN] | Gemfibrozil [USAN:USP:INN:BAN] | Gemfibrozil for system suitability, European Pharmacopoeia (EP) Reference Standard |
Gemfibrozil(Lopid) | Gemfibrozil, 98% | Gemfibrozil, British Pharmacopoeia (BP) Reference Standard |
Gemfibrozil, European Pharmacopoeia (EP) Reference Standard | Gemfibrozil, Pharmaceutical Secondary Standard | Gemfibrozil, United States Pharmacopeia (USP) Reference Standard |
Gemfibrozil, analytical standard | Gemfibrozil,(S) | Gemfibrozilo |
Gemfibrozilo [INN-Spanish] | Gemfibrozilum | Gemfibrozilum [INN-Latin] |
Gemlipid | Gemnpid | Gen-Fibro |
Gevilon Uno | Gozid | H900 |
HEMJJKBWTPKOJG-UHFFFAOYSA-N | HMS1568L09 | HMS1920B07 |
HMS2090K14 | HMS2091H11 | HMS2095L09 |
HMS2230H24 | HMS3259M12 | HMS3655C06 |
HMS3712L09 | HMS500G20 | HSDB 7735 |
HY-B0258 | Hidil | Hipolixan |
IDI1_000138 | Innogem | Innogen |
Ipolipid | J10068 | Jezil |
KBio1_000138 | KBio2_001305 | KBio2_003873 |
KBio2_006441 | KBio3_001280 | KBioGR_000964 |
KBioSS_001305 | KS-00000VK6 | KS-000046JO |
KS-5192 | LS-1085 | Lanaterom |
Lifibron | Lipazil | Lipigem |
Lipira | Lipizyl | Lipozid |
Lipur | Litarek | Lopid |
Lopid (TN) | Lopid R | Low-Lip |
MCULE-4563546953 | MFCD00079335 | MLS000028421 |
MLS001055364 | MLS006011850 | Micolip |
NC00565 | NCGC00016794-01 | NCGC00016794-02 |
NCGC00016794-03 | NCGC00016794-04 | NCGC00016794-05 |
NCGC00016794-06 | NCGC00016794-07 | NCGC00016794-08 |
NCGC00016794-09 | NCGC00016794-10 | NCGC00016794-11 |
NCGC00016794-13 | NCGC00016794-14 | NCGC00022722-03 |
NCGC00022722-04 | NCGC00022722-05 | NCGC00022722-06 |
NCGC00022722-07 | NCGC00256601-01 | NCGC00259546-01 |
NINDS_000138 | NSC-757024 | NSC757024 |
Normolip | Opera_ID_1658 | PEROXISOME PROJECT (GEMFIBROZIL) (SEE ALSO GEMFIBROZIL) |
Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl- | Pharmakon1600-10500313 | Pilder |
Polyxit | Prestwick0_000214 | Prestwick1_000214 |
Prestwick2_000214 | Prestwick3_000214 | Prestwick_637 |
Progemzal | Q384295 | Q8X02027X3 |
Reducel | Regulip | Renabrazin |
SAM002564211 | SBB012457 | SBI-0051391.P003 |
SC-17669 | SCHEMBL4813 | SEL11160931 |
SMR000058393 | SPBio_001174 | SPBio_002148 |
SPECTRUM1500313 | SR-01000000056 | SR-01000000056-3 |
SR-01000000056-4 | SR-01000000056-6 | SR-01000000056-7 |
ST072198 | STK618740 | SW196802-3 |
Sinelip | Spectrum2_001097 | Spectrum3_000440 |
Spectrum4_000562 | Spectrum5_000750 | Spectrum5_001991 |
Spectrum_000825 | Synbrozil | TEVA-A |
Taborcil | Tentroc | Tox21_110613 |
Tox21_110613_1 | Tox21_201997 | Tox21_302784 |
Trialmin | UNII-Q8X02027X3 | VA11004 |
Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)- | W-107216 | WL-Gemfibrozil |
Z-0832 | ZINC1530641 | ZX-AS004442 |
dimethylpentanoic acid | gemfibrozil | s1729 |
DrugBank Name | Gemfibrozil |
DrugBank | DB01241 |
CAS Number | 114413-98-8, 25812-30-0 |
PubChem Compound | 3463 |
KEGG Compound ID | C07020 |
KEGG Drug | D00334 |
PubChem.Substance | 46508264 |
ChEBI | 5296 |
PharmGKB | PA449750 |
ChemSpider | 3345 |
BindingDB | 50110590.0 |
TTD | DAP000210 |
Wikipedia | Gemfibrozil |
HET | 4TX |
DPD | 1904 |